CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo

@article{Lapteva2005CXCR4KB,
  title={CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo},
  author={N. Lapteva and A. Yang and Denise E Sanders and Randall W Strube and S. Chen},
  journal={Cancer Gene Therapy},
  year={2005},
  volume={12},
  pages={84-89}
}
  • N. Lapteva, A. Yang, +2 authors S. Chen
  • Published 2005
  • Medicine, Biology
  • Cancer Gene Therapy
  • Breast cancer cells express the chemokine receptor CXCR4 and frequently metastasize to organs with an abundant source of the CXCR4 ligand, stromal cell-derived factor 1 (SDF-1). The chemokine receptor CXCR4 plays an active role in the metastasis of breast cancer. Here, we show that a small interfering RNA (siRNA) against CXCR4 effectively downregulates CXCR4 expression in human MDA-MB-231 breast cancer cells, leading to significant decrease in breast cancer cell invasion and adhesion. It was… CONTINUE READING
    Multiple functions of CXCL12 in a syngeneic model of breast cancer
    55
    SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium.
    104
    G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis
    24

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 30 REFERENCES
    Involvement of chemokine receptors in breast cancer metastasis
    4775
    Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo
    430
    CXCR4/CXCL12 expression and signalling in kidney cancer
    248